Yesterday, the pharmaceutical company Pfizer announced its coronavirus vaccine trial was effective at preventing infections in 90% of previously uninfected people.
As of now, there don't yet appear to be any serious safety concerns associated with the vaccine. This could be a major breakthrough in the fight against the virus, but there's still a lot left to figure out.
- Plus, Trump loyalists tell federal employees the election isn’t over yet.
- And, pollster problems post-vote.
Guests: Axios' Sam Baker, Jonathan Swan, and Sara Kehaulani Goo.
Credits: "Axios Today" is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Carol Wu, Cara Shillenn, Nuria Marquez Martinez, Dan Bobkoff, Sara Kehaulani Goo, Alex Sugiura and Naomi Shavin. Music is composed by Evan Viola. You can reach us at podcasts@axios.com.
Go deeper:
